<p>TORONTO, Canada — The United States Food and Drug Administration has issued a warning letter to a company that appears to sell products containing human fecal matter without approval from the a
</p><p>This type of therapy should only be used in the context of an authorized clinical trial, or to treat patients with recurrent Clostridium difficile, also known as C.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: